LBA01-10 MIRABEGRON FOR TREATMENT OF OVERACTIVE BLADDER SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE: A DOUBLE-BLIND, RANDOMIZED PLACEBO-CONTROLLED TRIAL | Zendy

AI Assistant Blog Pricing

LBA01-10 MIRABEGRON FOR TREATMENT OF OVERACTIVE BLADDER SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE: A DOUBLE-BLIND, RANDOMIZED PLACEBO-CONTROLLED TRIAL

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.